Medication Error Guidelines
Contents |
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug
Medication Errors Definition
Safety and Availability Medication Errors Medication Errors Related to Drugs Share Tweet medication error in nursing Linkedin Pin it More sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research
Types Of Medication Errors
(CDER), the Division of Medication Error Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating causes of medication error Council for Medication Error Reporting and Prevention (NCCMERP) definition of a medication error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including medication error examples prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to
Portal Advanced search Portal Home Search Titles A-Z Subjects Keywords Series and Periodicals Publishers Authors A-Z Regions Countries Index Sub-collections Public sub-collections Loading... Subjects & KeywordsAll >
Ema Medication Errors
Quality and Safety: Medicines > Quality AssuranceAll > Quality and Safety: Medicines medication error classification > Safety and EfficacyKeywords > guidelinesKeywords > inappropriate useKeywords > medication errorsKeywords > quality assuranceKeywords > reportingKeywords >
Medication Error Prevention
reporting systemKeywords > safetyGuideline on Medication Error Reporting, First Edition, July 2009 - Malaysia (2009; 30 pages) Abstract The Pharmaceutical Services Division, Ministry of Health Malaysia had introduced the http://www.fda.gov/drugs/drugsafety/medicationerrors/ Pharmacy Quality Assurance Program since the 1980’s. Data collected related to medication safety includes prescriptions intervened, wrongly dispensed medications and wrongly filled medications (but detected before dispensing) at hospitals and clinics. However, the information obtained was only limited to prescribing and dispensing practices. There were no data available on other processes in the medicines management cycle such as preparation http://apps.who.int/medicinedocs/en/d/Js17803en/ and administration of medications. Hence, there is a need for a reporting system that incorporates all processes involved in the management of medicines to collect and collate relevant information for necessary remedial actions. With guidance and cooperation of the Medication Safety Technical Advisory Committee, the Pharmaceutical Services Division has embarked on a reporting system called the Medication Error Reporting System (MERS). The aim of this system is to establish a database on medication errors which includes all error reports related to medication use in the prescribing, administration, dispensing and preparation... View the PDF document Sitemap Search Titles A-Z Subjects Keywords Series and Periodicals Publishers Authors A-Z Regions Countries Index Sub-collections Public sub-collections Help and Services Contacts FAQs Employment Feedback Privacy E-mail scams WHO.INT WHO Home WHO Health Systems and Services WHO Medicines WHO sites Connect with WHO RSS Feeds WHO YouTube channel Follow WHO on Twitter WHO Facebook page © WHO 2016 The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: September 2, 2016
Me Forgot Password? Login or Sign up for a Free Account My Topics of Interest My CME My Profile Sign Out Home Topics Issues https://psnet.ahrq.gov/primers/primer/23/medication-errors WebM&M Cases Perspectives Primers Submit Case CME / CEU Training Catalog Info Glossary About PSNet Help & FAQ Contact PSNet Email Updates Editorial Team Technical Expert/Advisory Panel Terms & Conditions / Copyright PSNet Privacy Policy External Link Disclaimer Patient Safety Primer Last Updated: March 2015 Medication Errors Topics Resource Type Patient Safety Primers medication error Safety Target Medication Errors/Preventable Adverse Drug Events Look-Alike, Sound-Alike Drugs More Share Facebook Twitter Linkedin Email Print Background and definitions Prescription medication use is widespread, complex, and increasingly risky. Clinicians have access to an armamentarium of more than 10,000 prescription medications, and nearly one-third of adults in the United States take 5 or of medication error more medications. Advances in clinical therapeutics have undoubtedly resulted in major improvements in health for patients with many diseases, but these benefits have also been accompanied by increased risks. An adverse drug event (ADE) is defined as harm experienced by a patient as a result of exposure to a medication, and ADEs account for nearly 700,000 emergency department visits and 100,000 hospitalizations each year. ADEs affect nearly 5% of hospitalized patients, making them one of the most common types of inpatient errors; ambulatory patients may experience ADEs at even higher rates. Transitions in care are also a well-documented source of preventable harm related to medications. As with the more general term adverse event, the occurrence of an ADE does not necessarily indicate an error or poor quality care. A medication error refers to an error (of commission or omission) at any step along the pathway that begins when a clinician prescribes a medication and ends when the patient act
be down. Please try the request again. Your cache administrator is webmaster. Generated Thu, 20 Oct 2016 12:19:58 GMT by s_wx1196 (squid/3.5.20)